Genevant Sciences
Richard Holland PhD is a seasoned professional in medicinal chemistry with extensive experience in the biopharmaceutical sector, currently serving as Senior Director of Chemistry at Genevant Sciences since April 2018. Holland has previously held key roles at Arbutus Biopharma Corporation, where responsibilities included designing proprietary targeting ligands and managing research collaborations. Holland also operated a consulting firm, assisting early-stage companies with strategic challenges, and oversaw significant financial responsibilities in restaurant management. With a PhD in Cancer Research and Medicinal Chemistry from The Institute of Cancer Research, Holland has a comprehensive background that spans oncology, cardiovascular, pain/CNS therapies, and antiviral research, underpinned by a commitment to innovative drug development.
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.